NCT03876665

Brief Summary

The purpose of this study is to understand the experience of living with polycystic ovary syndrome (PCOS) as an active duty Service Woman. As part of a budding research program, this proposed study will lay the groundwork for future intervention studies targeting the management of PCOS in a military population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

August 15, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

February 23, 2021

Status Verified

February 1, 2021

Enrollment Period

1.4 years

First QC Date

February 26, 2019

Last Update Submit

February 19, 2021

Conditions

Keywords

Polycystic Ovary SyndromeMilitaryService WomenActive Duty

Outcome Measures

Primary Outcomes (2)

  • Describe the PCOS experience of active duty service members

    Information from focused groups (FG) discussions and individual interviews (II) will be transcribed, categorized and then organized into themes that describe the experiences of active duty service members

    through study completion, up to 18 months

  • Describe the PCOS experience by branch of service

    Information from focused groups (FG) discussions and individual interviews (II) will be transcribed, categorized and then organized into themes that describe the experiences by branch of service

    through study completion, up to 18 months

Study Arms (1)

Focus Group

Active Duty Air Force, Army and Navy women diagnosed with PCOS. Up to three focus groups per service branch will be conducted. Considering attrition for those who may volunteer and not show up for the FG session, the investigators will recruit up to 20 participants per site, with the goal of including a maximum of six participants per FG to maximize individual participation.

Other: No intervention

Interventions

No intervention

Focus Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale specific condition
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Active duty military women diagnosed with PCOS

You may qualify if:

  • Women, active duty or prior (within 5 years) in the Army, Navy, Air Force or Marine Corps
  • Diagnosed with PCOS
  • years of age or over

You may not qualify if:

  • Reservist, Coast Guard, women who have separated or retired \> 5 years ago

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

David Grant Medical Center

Travis Air Force Base, California, 94535, United States

Location

Related Publications (4)

  • Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009 Feb;91(2):456-88. doi: 10.1016/j.fertnstert.2008.06.035. Epub 2008 Oct 23.

    PMID: 18950759BACKGROUND
  • Yildizhan B, Anik Ilhan G, Pekin T. The impact of insulin resistance on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome. J Obstet Gynaecol. 2016 Oct;36(7):893-896. doi: 10.3109/01443615.2016.1168376. Epub 2016 May 3.

    PMID: 27140180BACKGROUND
  • Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008 Mar;23(3):462-77. doi: 10.1093/humrep/dem426.

    PMID: 18308833BACKGROUND
  • Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010 Jun 30;8:41. doi: 10.1186/1741-7015-8-41.

    PMID: 20591140BACKGROUND

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Dawnkimberly Hopkins, PhD

    David Grant Medical Center

    PRINCIPAL INVESTIGATOR
  • Leilani Siaki, PhD

    Madigan Army Medical Center

    PRINCIPAL INVESTIGATOR
  • Abigail Yablonsky, PhD

    United States Naval Medical Center, San Diego

    PRINCIPAL INVESTIGATOR
  • Angela Phillips, PhD

    Malcolm Grow Medical Clinics and Surgery Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2019

First Posted

March 15, 2019

Study Start

August 15, 2019

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

February 23, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations